Bo Liang Email & Phone Number

Dr. Bo Liang is a serial entrepreneur and an experienced scientist with extensive experience in pharmaceutical drug development and chemical/composite materials industry. Dr. Liang is currently Co-founder, Chairman & CEO of IVIEW Therapeutics Inc. IVIEW Therapeutics Inc. is a clinical-stage ophthalmology-focused therapeutics company based in Cranbury, New Jersey committed to the treatment of ocular diseases with high unmet medical needs through innovative small molecule drugs and gene therapy approaches. Our focus on novel mechanisms of action combined with our proprietary drug delivery technology platforms allows us to bring forward highly differentiated assets with potentially superior target product profiles. Currently, our portfolio includes novel products to treat Acute Infectious Conjunctivitis, Dry Eye Disease (DED), Myopia, presbyopia and Glaucoma.IVIEW has built an exceptional team with ophthalmologists, pharmaceutical experts with entrepreneurial experience to execute on its drug development programs. IVIEW’s strategy has been externally validated with an investment of over $40M in three tranches from well-known VCs.Dr. Liang also co-founded Adesso Advanced Materials in 2010. Adesso invented the first recyclable epoxies in the world and "Recycloset and Cleavamine" were recognized as the JEC-Asia 2012 Innovation Award and 2016 & 2017 US TechConnect National Innovation Award. Prior to that, Dr. Liang was Executive Vice President at Foresight Biotherapeutics in New York city. In 2006, Dr. Liang co-founded CLS Pharmaceuticals and managed R&D and advanced the development of an eye drug into phase II clinical trials, leading to out-license to Foresight, which later was acquired by Shire in 2015 with $300m cash after a successful phase II trial of the program. Dr. Liang was a Senior Scientist at Pharmacopeia where he spent six years in drug discovery and advanced a novel drug candidate from research to clinical trials to treat human respiratory disease. Before he came to US, Dr. Liang had 3 years entrepreneurial and marketing experience in Beijing, China.Dr. Liang held over fifty issued or pending US and international PCT patents. He has published over 15 articles in various scientific journals and has served as a reviewer for Bioorganic & Medicinal Chemistry.

Listed skills include Drug Discovery, R&D, Pharmaceutical Industry, Patents, and 14 others.